CREATIVE REALITIES INC (CREX) Stock Fundamental Analysis
NASDAQ:CREX - Nasdaq - US22530J3095 - Common Stock - Currency: USD
We assign a fundamental rating of 3 out of 10 to CREX. CREX was compared to 97 industry peers in the Media industry. Both the profitability and financial health of CREX have multiple concerns. CREX is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year CREX was profitable.
CREX had a negative operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: CREX reported negative net income in multiple years.
The reported operating cash flow has been mixed in the past 5 years: CREX reported negative operating cash flow in multiple years.
1.2 Ratios
CREX has a Return On Assets (-0.05%) which is in line with its industry peers.
CREX has a Return On Equity (-0.10%) which is in line with its industry peers.
Looking at the Return On Invested Capital, with a value of 0.43%, CREX is doing worse than 62.89% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.05% | ||
| ROE | -0.1% | ||
| ROIC | 0.43% |
ROA(3y)-2.23%
ROA(5y)-17.47%
ROE(3y)-5.54%
ROE(5y)-80.4%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With a Operating Margin value of 0.60%, CREX is not doing good in the industry: 61.86% of the companies in the same industry are doing better.
With a Gross Margin value of 46.99%, CREX perfoms like the industry average, outperforming 55.67% of the companies in the same industry.
In the last couple of years the Gross Margin of CREX has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 0.6% | ||
| PM (TTM) | N/A | ||
| GM | 47% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.36%
GM growth 5Y1.66%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CREX is destroying value.
Compared to 1 year ago, CREX has more shares outstanding
The number of shares outstanding for CREX has been increased compared to 5 years ago.
Compared to 1 year ago, CREX has a worse debt to assets ratio.
2.2 Solvency
CREX has an Altman-Z score of 0.25. This is a bad value and indicates that CREX is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 0.25, CREX is not doing good in the industry: 64.95% of the companies in the same industry are doing better.
A Debt/Equity ratio of 0.78 indicates that CREX is somewhat dependend on debt financing.
CREX has a Debt to Equity ratio (0.78) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.78 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 0.25 |
ROIC/WACC0.06
WACC7.45%
2.3 Liquidity
CREX has a Current Ratio of 1.23. This is a normal value and indicates that CREX is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.23, CREX is in line with its industry, outperforming 42.27% of the companies in the same industry.
A Quick Ratio of 1.10 indicates that CREX should not have too much problems paying its short term obligations.
The Quick ratio of CREX (1.10) is worse than 61.86% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.23 | ||
| Quick Ratio | 1.1 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 309.09% over the past year.
CREX shows a small growth in Revenue. In the last year, the Revenue has grown by 1.67%.
Measured over the past years, CREX shows a quite strong growth in Revenue. The Revenue has been growing by 9.98% on average per year.
EPS 1Y (TTM)309.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%7900%
Revenue 1Y (TTM)1.67%
Revenue growth 3Y40.23%
Revenue growth 5Y9.98%
Sales Q2Q%-20.77%
3.2 Future
CREX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 73.78% yearly.
CREX is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 13.96% yearly.
EPS Next Y181.91%
EPS Next 2Y73.78%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year9.28%
Revenue Next 2Y13.96%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 7.17 indicates a rather cheap valuation of CREX.
CREX's Price/Earnings ratio is rather cheap when compared to the industry. CREX is cheaper than 85.57% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.45, CREX is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 9.80, the valuation of CREX can be described as reasonable.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CREX indicates a somewhat cheap valuation: CREX is cheaper than 73.20% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of CREX to the average of the S&P500 Index (21.90), we can say CREX is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.17 | ||
| Fwd PE | 9.8 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CREX is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 12.16 |
4.3 Compensation for Growth
CREX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as CREX's earnings are expected to grow with 73.78% in the coming years.
PEG (NY)0.04
PEG (5Y)N/A
EPS Next 2Y73.78%
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for CREX!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
3.3
-0.09 (-2.65%)
Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)
Earnings (Next)
Inst Owners18.11%
Inst Owner Change-8.75%
Ins Owners16.42%
Ins Owner Change4.94%
Market Cap34.72M
Analysts84
Price Target5.61 (70%)
Short Float %1.07%
Short Ratio0.61
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)230.68%
Min EPS beat(2)-140.1%
Max EPS beat(2)601.45%
EPS beat(4)3
Avg EPS beat(4)160.43%
Min EPS beat(4)-140.1%
Max EPS beat(4)601.45%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-3.64%
Min Revenue beat(2)-11.52%
Max Revenue beat(2)4.23%
Revenue beat(4)3
Avg Revenue beat(4)-0.84%
Min Revenue beat(4)-11.52%
Max Revenue beat(4)4.23%
Revenue beat(8)3
Avg Revenue beat(8)-4.2%
Revenue beat(12)3
Avg Revenue beat(12)-4.26%
Revenue beat(16)3
Avg Revenue beat(16)-3.68%
PT rev (1m)-16.98%
PT rev (3m)-24.14%
EPS NQ rev (1m)-9.53%
EPS NQ rev (3m)-291.67%
EPS NY rev (1m)221.84%
EPS NY rev (3m)130.44%
Revenue NQ rev (1m)-1.37%
Revenue NQ rev (3m)-22.61%
Revenue NY rev (1m)-0.02%
Revenue NY rev (3m)-7.06%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.17 | ||
| Fwd PE | 9.8 | ||
| P/S | 0.72 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 1.16 | ||
| P/tB | N/A | ||
| EV/EBITDA | 12.16 |
EPS(TTM)0.46
EY13.94%
EPS(NY)0.34
Fwd EY10.2%
FCF(TTM)-0.34
FCFYN/A
OCF(TTM)-0.1
OCFYN/A
SpS4.59
BVpS2.84
TBVpS-1.8
PEG (NY)0.04
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.05% | ||
| ROE | -0.1% | ||
| ROCE | 0.55% | ||
| ROIC | 0.43% | ||
| ROICexc | 0.44% | ||
| ROICexgc | 6.2% | ||
| OM | 0.6% | ||
| PM (TTM) | N/A | ||
| GM | 47% | ||
| FCFM | N/A |
ROA(3y)-2.23%
ROA(5y)-17.47%
ROE(3y)-5.54%
ROE(5y)-80.4%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.36%
GM growth 5Y1.66%
F-Score3
Asset Turnover0.72
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.78 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 4.93 | ||
| Cap/Depr | 58.56% | ||
| Cap/Sales | 5.37% | ||
| Interest Coverage | 0.26 | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.23 | ||
| Quick Ratio | 1.1 | ||
| Altman-Z | 0.25 |
F-Score3
WACC7.45%
ROIC/WACC0.06
Cap/Depr(3y)115.1%
Cap/Depr(5y)95.1%
Cap/Sales(3y)8.11%
Cap/Sales(5y)6.88%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)309.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%7900%
EPS Next Y181.91%
EPS Next 2Y73.78%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)1.67%
Revenue growth 3Y40.23%
Revenue growth 5Y9.98%
Sales Q2Q%-20.77%
Revenue Next Year9.28%
Revenue Next 2Y13.96%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-78.53%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year709.43%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-40%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-151.33%
OCF growth 3Y93.04%
OCF growth 5YN/A